TABLE 1

Comparison of potency and maximum response of agonist-induced [35S]GTPγS binding and arrestin-3 recruitment for 22 opioid agonists acting at MOPr in HEK293 cells

Agonists are positioned in the table according to potency in the [35S]GTPγS binding assay, the most potent agonist (etorphine) being positioned at the top. Also shown are KD values for the agonists as determined in [3H]naloxone competition binding experiments. Max Response columns indicate maximum [35S]GTPγS response for each agonist expressed relative to that obtained for DAMGO (taken as 1) and maximum arrestin-3 recruitment response for each agonist expressed relative to alfentanil (taken as 1), respectively. Apart from the exceptions noted, values represent mean ± S.E.M. of at least three independent experiments for each agonist.

Agonist[35S]GTPγS BindingArrestin-3 RecruitmentKD
EC50Max ResponseEC50Max Response
nMnMnM
Etorphine0.55 ± 0.160.92 ± 0.066.8 ± 1.01.22 ± 0.083.5 ± 0.3
Norbuprenorphine1.7 ± 0.70.93 ± 0.0284.6 ± 12.11.16 ± 0.0924.6 ± 4.5
Met-enkephalin7.7 ± 1.90.88 ± 0.06939 ± 3251.38 ± 0.16281 ± 13
DAMGO11.2 ± 1.931.04 ± 0.02414 ± 901.24 ± 0.09228 ± 74
Buprenorphine14.5 ± 5.110.55 ± 0.04a0.9 ± 0.1
Leu-enkephalin30.9 ± 12.00.87 ± 0.055160 ± 14900.94 ± 0.10744 ± 84
Levorphanol33.1 ± 17.20.98 ± 0.11265 ± 1120.24 ± 0.0323.2 ± 2.2
Fentanyl56.8 ± 31.21.14 ± 0.11210 ± 420.89 ± 0.13158 ± 24
Pentazocine77.9b0.26b149 ± 27
6MAM73.3 ± 26.10.96 ± 0.031540 ± 7000.45 ± 0.07318 ± 86
M6G81.0 ± 27.70.87 ± 0.061600 ± 3700.27 ± 0.05437 ± 227
Methadone87.2 ± 42.21.18 ± 0.092110 ± 9991.14 ± 0.16552 ± 81
Alfentanil90.3 ± 16.20.99 ± 0.01638 ± 1921.01 ± 0.16866 ± 156
Morphine97.5 ± 28.50.98 ± 0.03322 ± 440.19 ± 0.03250 ± 52
Endomorphin 2138 ± 311.04 ± 0.04311 ± 1211.22 ± 0.01283 ± 54
Endomorphin 1183 ± 961.11 ± 0.11226 ± 430.95 ± 0.04281 ± 31
Normorphine259 ± 1651.11 ± 0.14768 ± 1650.52 ± 0.09578 ± 141
Meptazinol289b0.38b462 ± 71
Oxycodone564 ± 1950.95 ± 0.121460 ± 12900.18 ± 0.031550 ± 328
Meperidine>10,000c7110 ± 3300
Cyclazocine>10,000c17500 ± 725
Nalorphine>10,000c13.1 ± 0.6
  • 6MAM, 6-monoacetylmorphine.

  • a It was not possible to determine values because maximum agonist response was not obtained or because of lack of significant response at highest agonist concentrations used.

  • b Values for these agonists determined from a curve fitted to the mean data, as it was not possible to obtain fits of individual curves.

  • c Estimation because maximum response was not obtained at the highest concentration of agonist used.